Organoclick (Sweden) Today
ORGC Stock | SEK 2.65 0.04 1.53% |
Performance0 of 100
| Odds Of DistressLess than 11
|
Organoclick is selling for under 2.65 as of the 29th of November 2024; that is 1.53 percent increase since the beginning of the trading day. The stock's last reported lowest price was 2.61. Organoclick has less than a 11 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Equity ratings for Organoclick AB are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 10th of December 2022 and ending today, the 29th of November 2024. Click here to learn more.
OrganoClick AB develops, produces, and markets functional materials in Sweden. OrganoClick AB was founded in 2006 and is headquartered in Tby, Sweden. OrganoClick operates under Research And Specialist Materials classification in Sweden and is traded on Stockholm Stock Exchange. The company has 97.95 M outstanding shares. More on Organoclick AB
Moving against Organoclick Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Organoclick Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Organoclick's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Organoclick or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Cofounder CEO | Marten Hellberg |
Business Concentration | Specialty Chemicals, Basic Materials (View all Sectors) |
Organoclick AB (ORGC) is traded on Stockholm Exchange in Sweden and employs 48 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 365.11 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Organoclick's market, we take the total number of its shares issued and multiply it by Organoclick's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Organoclick AB operates under Basic Materials sector and is part of Specialty Chemicals industry. The entity has 97.95 M outstanding shares.
Organoclick AB has accumulated about 34.25 M in cash with (37.69 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.11.
Check Organoclick Probability Of Bankruptcy
Ownership AllocationOrganoclick owns a total of 97.95 Million outstanding shares. Organoclick has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Organoclick Ownership Details
Organoclick AB Risk Profiles
Although Organoclick's alpha and beta are two of the key measurements used to evaluate Organoclick's performance over the market, the standard measures of volatility play an important role as well.
Mean Deviation | 1.87 | |||
Standard Deviation | 2.72 | |||
Variance | 7.41 | |||
Risk Adjusted Performance | (0.03) |
Organoclick Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Organoclick without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Anywhere Now
Portfolio AnywhereTrack or share privately all of your investments from the convenience of any device |
All Next | Launch Module |
Organoclick Corporate Management
Elected by the shareholders, the Organoclick's board of directors comprises two types of representatives: Organoclick inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Organoclick. The board's role is to monitor Organoclick's management team and ensure that shareholders' interests are well served. Organoclick's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Organoclick's outside directors are responsible for providing unbiased perspectives on the board's policies.
Mattias Bodin | Environmental Director | Profile | |
Mikael Wickstrm | Technical Director | Profile | |
Jessica Sundborg | Chief Officer | Profile | |
Daniel Lund | Chief Officer | Profile | |
Maria Wennman | RD Director | Profile |
Additional Tools for Organoclick Stock Analysis
When running Organoclick's price analysis, check to measure Organoclick's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Organoclick is operating at the current time. Most of Organoclick's value examination focuses on studying past and present price action to predict the probability of Organoclick's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Organoclick's price. Additionally, you may evaluate how the addition of Organoclick to your portfolios can decrease your overall portfolio volatility.